Showing results (491-500 of 515) with videos related to
Sort By:
Pageof 52
Pharmacoepidemiology and Drug Safety|May 23, 2009
Reasons for non-response in observational pharmacogenetic researchDiane B M A van Wieren-de Wijer, Anke-Hilse Maitland-van der Zee, Anthonius de Boer, et al.Pharmacogenetics and Genomics|June 14, 2008
Effectiveness of statins in the reduction of the risk of myocardial infarction is modified by the GNB3 C825T variantBas J M Peters, Anke-Hilse Maitland-van der Zee, Bruno H Ch Stricker, et al.Journal of Hypertension|May 6, 2004
Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe TrialJan A Staessen, Lutgarde Thijisq, Robert Fagard, et al.Nutrients|October 31, 2015
Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial)Liv M Vossen, Leon J Schurgers, Bernard J van Varik, et al.European Journal of Epidemiology|September 18, 2009
Determinants of DNA yield and purity collected with buccal cell samplesD B M A van Wieren-de Wijer, A H Maitland-van der Zee, A de Boer, et al.Lancet (London, England)|September 23, 1997
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial InvestigatorsJ A Staessen, R Fagard, L Thijs, et al.Archives of Internal Medicine|August 13, 1998
Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the ElderlyJ A Staessen, R Fagard, L Thijs, et al.Hypertension (Dallas, Tex. : 1979)|March 26, 2003
Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIERCarl Erik Mogensen, Giancarlo Viberti, Serge Halimi, et al.Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|February 19, 2002
Amelioration of arterial properties with a perindopril-indapamide very-low-dose combinationR G Asmar, G M London, M E O'Rourke, et al.Trials|January 18, 2011
Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxinJan A Staessen, Lutgarde Thijs, Katarzyna Stolarz-Skrzypek, et al.Pageof 52